SCHEMBL19203130

SCHEMBL19203130

Cc1ccc2c(O)c(O)c(O)c(O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 3/20 0.47
▸ LDHB P07195 3/20 0.47
▸ TRPA1 O75762 2/20 0.46
▸ TP53 P04637 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ ALB P02768 2/20 0.43
▸ ALOX15 P16050 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ PKM P14618 1/20 0.40
▸ LMNA P02545 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CYP1A2 P05177 3/20 0.39
▸ ACHE P22303 2/20 0.39
▸ CYP2A6 P11509 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566699 0.92 LDHA (0.48) LDHALDHBTRPA1TP53TDP1
SCHEMBL21751239 0.92 LDHA (0.48) LDHALDHBTRPA1TP53TDP1
SCHEMBL29566489 0.85 PKM (0.52) LDHALDHBTRPA1TP53TDP1
SCHEMBL21751240 0.85 PKM (0.52) LDHALDHBTRPA1TP53TDP1
SCHEMBL30226666 0.83 LDHA (0.43) LDHALDHBTRPA1TP53TDP1
SCHEMBL14949885 0.80 MCL1 (0.43) LDHALDHBTRPA1TP53TDP1
SCHEMBL19202493 0.80 LDHA (0.72) LDHALDHBALB
SCHEMBL19202489 0.80 LDHA (0.67) LDHALDHBTDP1ALBALDH1A1
SCHEMBL19202492 0.80 LDHA (0.67) LDHALDHBTDP1ALBALDH1A1
SCHEMBL19202488 0.80 LDHA (0.77) LDHALDHBALBALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE ORMCO CORPORATION 2017-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE SP1, GPER1, GRIN1 LDHA 2656/4885LDHB 2298/4885TRPA1 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback